Danish hearing aid companies are world-leading in the global market for hearing devices, taking up a share of more than 60 percent in the global market, and WS Audiology, especially, contributes to Denmark's position in the global vanguard when it comes to the development of new hearing aid solutions, according to a recent 2021 report from the World Intellectual Property Organization (WIPO) which uses patent and other data from 1998 to 2019 to provide factual information on global innovation in assistive technologies.
In the 30 most active patent applications, Danish-domiciled WSA takes first place by far, measured by number of patent families within the category 'conventional hearing aid technology' in the last 21 years.
More from MedWatch
In 2015, Genmab partnered with relatively unknown biotech firm Biontech. Reflecting on how far Genmab has come since, CEO Jan van de Winkel is still confident that partnerships, rather than acquisitions, are the way forward. If it had acquired Biontech at the time, the CEO speculates Genmab may have put a stop to other activities – including the Covid-19 vaccine efforts that went on to save millions of lives. This and fairness are worth remembering as biotech firms are increasingly strapped for cash, van de Winkel reflects.